Gregory S. Patrick is CFO & VP at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 15 open-market trades across 1 company since 2012, most recently 2020-11-09.
CIK 0001219844
1 open-market purchase totalling $50K since 2012, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 49,463 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2020-11-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL | 2020-11-09 | 2020-11-10 | $25.00 | $125K | -2.4% | +2.8% | +44.2% |
| SUPN | SELL | 2020-11-05 | 2020-11-06 | $23.00 | $115K | -14.0% | -13.8% | +16.1% |
| SUPN | SELL | 2020-10-15 | 2020-10-15 | $20.03 | $300K | -7.4% | +9.9% | +38.8% |
| SUPN | SELL | 2020-05-20 | 2020-05-20 | $25.03 | $375K | -0.3% | -0.5% | +5.2% |
| SUPN | SELL | 2020-05-08 | 2020-05-11 | $23.14 | $347K | +2.7% | +0.3% | -2.4% |
| SUPN | SELL | 2019-02-27 | 2019-02-28 | $41.53 | $831K | -6.2% | -12.6% | -21.5% |
| SUPN | SELL | 2018-07-02 | 2018-07-03 | $56.63 | $2.0M | -1.9% | +1.1% | -8.6% |
| SUPN | SELL | 2018-01-11 | 2018-01-12 | $43.56 | $2.2M | -3.2% | -13.0% | +3.7% |
| SUPN | SELL | 2017-09-08 | 2017-09-11 | $48.89 | $1.1M | -18.4% | -14.7% | -21.4% |
| SUPN | SELL | 2017-09-07 | 2017-09-11 | $46.36 | $1.2M | -18.4% | -14.7% | -21.4% |
| SUPN | SELL | 2017-09-07 | 2017-09-11 | $48.01 | $3.5M | -18.4% | -14.7% | -21.4% |
| SUPN | SELL | 2017-04-24 | 2017-04-26 | $32.37 | $3.5M | -4.3% | +7.2% | +28.3% |
| SUPN | SELL | 2016-09-16 | 2016-09-16 | $25.00 | $50K | +4.8% | -18.8% | -7.1% |
| SUPN | SELL | 2016-07-14 | 2016-07-15 | $22.00 | $75K | +8.9% | +12.0% | +8.3% |
| SUPN | SELL · 10b5-1 | 2015-07-16 | 2015-07-16 | $20.00 | $124K | -17.4% | -0.2% | -0.2% |
| SUPN | BUY | 2013-03-14 | 2013-03-15 | $6.95 | $35K | -17.4% | -0.2% | -0.2% |
| SUPN | BUY | 2012-05-04 | 2012-05-07 | $5.00 | $15K | -17.4% | -0.2% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.